Premium
Chronic vulvovaginal candidiasis in patients using a levonorgestrel‐containing intrauterine device
Author(s) -
Nguyen Yvonne,
Fischer Gayle
Publication year - 2018
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.12559
Subject(s) - fluconazole , medicine , vulvovaginal candidiasis , levonorgestrel , intrauterine device , antifungal , mycosis , gynecology , obstetrics , family planning , dermatology , surgery , population , research methodology , environmental health
Chronic vulvovaginal candidiasis is usually responsive to therapy with oral antifungals. We present a case series of 13 patients with this condition who were also using a levonorgestrel intrauterine system ( LNG ‐ IUS ). All cases responded to ongoing oral fluconazole therapy while the LNG ‐ IUS was in situ . The LNG ‐ IUS was removed in six patients and of these, two experienced clinical improvement with lower fluconazole dosage requirements and three experienced complete resolution of symptoms. One remains on fluconazole 100 mg daily.